We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
17:00 - 18:00
A1 Plenary
Breast cancer 2: Minimising treatment while maximising outcomes
Cristina Gutiérrez Miguélez, Spain;
SENEM ALANYALI, Turkey
Proffered Papers
Clinical
17:00 - 18:00
Long terms results of radiation therapy de-escalation in cT1-2N1 breast cancer after primary systemic treatment (RAPCHEM, BOOG 2010-03; NCT01279304)
Fleur Mauritz, The Netherlands
-1246
17:00 - 18:00
Is a boost to the tumour bed still indicated after breast-conserving surgery and whole-breast radiotherapy in the era of modern systemic therapy?
Femke Froklage, The Netherlands
-4723
17:00 - 18:00
Eliminating surgery for breast cancers with an exceptional response to ablative radiotherapy: phase 2 trial primary endpoints
Simona Shaitelman, USA
-4177
17:00 - 18:00
Patterns of locoregional and distant recurrence and dosimetric analysis in the HypoG-01 phase III trial
Louis Munschi, France
-3330
17:00 - 18:00
Randomized controlled trial comparing 5 and 15 fractions for whole breast and nodal irradiation with boost after breast-conserving surgery NCT03677427
Renée De Noyette, Belgium
-1633
17:00 - 18:00
STARS Pilot Randomised Study of Anastrozole and radiotherapy sequencing for adjuvant treatment of breast cancer NCT00126360 10 year results
Peter Graham, Australia
-4160